References:
1. Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA Vaccine against
SARS-CoV-2 — Preliminary Report. N Engl J Med .
2020;383(20):1920-1931. doi:10.1056/NEJMoa2022483
2. Hendaus MA, Jomha FA. mRNA Vaccines for COVID-19: A Simple
Explanation. Qatar Med J . 2021;2021(1). doi:10.5339/qmj.2021.7
3. Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 Vaccine
After Reports of Myocarditis Among Vaccine Recipients: Update from the
Advisory Committee on Immunization Practices — United States, June
2021. MMWR Morb Mortal Wkly Rep . 2021;70(27):977-982.
doi:10.15585/mmwr.mm7027e2
4. Hudson B, Mantooth R, DeLaney M. Myocarditis and pericarditis after
vaccination for COVID‐19. J Am Coll Emerg Physicians Open .
2021;2(4). doi:10.1002/emp2.12498
5. Lazaros G, Klein AL, Hatziantoniou S, Tsioufis C, Tsakris A,
Anastassopoulou C. The Novel Platform of mRNA COVID-19 Vaccines and
Myocarditis: Clues into the Potential Underlying Mechanism.Vaccine . 2021;39(35):4925-4927. doi:10.1016/j.vaccine.2021.07.016
6. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the
diagnosis and management of pericardial diseases. Eur Heart J .
2015;36(42):2921-2964. doi:10.1093/eurheartj/ehv318
7. Chetrit M, Xu B, Verma BR, Klein AL. Multimodality Imaging for the
Assessment of Pericardial Diseases. Curr Cardiol Rep .
2019;21(5):41. doi:10.1007/s11886-019-1115-y
8. Imazio M, Pivetta E, Palacio Restrepo S, et al. Usefulness of Cardiac
Magnetic Resonance for Recurrent Pericarditis. Am J Cardiol .
2020;125(1):146-151. doi:10.1016/j.amjcard.2019.09.026
9. Dionne A, Sperotto F, Chamberlain S, et al. Association of
Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case
Series of Children. JAMA Cardiol . Published online August 10,
2021. doi:10.1001/jamacardio.2021.3471
10. Klein AL, Imazio M, Cremer P, et al. Phase 3 Trial of Interleukin-1
Trap Rilonacept in Recurrent Pericarditis. N Engl J Med .
2021;384(1):31-41. doi:10.1056/NEJMoa2027892